Clinical Trial of Expanded and Activated Autologous NK Cells to Treat Multiple Myeloma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The purpose of this study is to determine wether activated and expanded autologous Natural Killer cells (NKAEs) are effective in the treatment of patients with multiple myeloma on second or later relapse. NKAEs are used in combination with anti-myeloma drugs such as lenalidomide or bortezomib.
Epistemonikos ID: f68cd2eadd19a7b6d827ef5d1bec5539f22ffda6
First added on: May 12, 2024